Precision prevention in ovarian cancer


Jingjing Liu and Youn Jin Choi*

Ovarian Cancer (OC) is the most lethal gynecologic malignancy but a timely diagnosis is limited because of the absence of effective biomarkers. Germline BRCA1/2 genetic alterations are risk factors for hereditary OC and a Risk-Reducing Salpingo-Oophorectomy (RRSO) is pursued to prevent disease. However, not all healthy carriers develop the disease and RRSO may cause complications such as menopausal symptoms and cardiac risks. In addition, RRSO may not prevent BRCA1/2-related primary peritoneal cancer. Therefore, it is necessary to find biomarkers for ‘selective’ RRSO and chemoprevention strategies against hereditary OC.

Share this article

Awards Nomination

Select your language of interest to view the total content in your interested language

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • CiteFactor
  • Electronic Journals Library
  • OCLC- WorldCat
  • Publons
  • Chemical Abstract Services (USA)
  • Academic Resource Index